Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,600 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Results of Phase III Randomized Trial for Use of Docetaxel as a Radiosensitizer in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based Chemoradiation.
Patil VM, Noronha V, Menon N, Singh A, Ghosh-Laskar S, Budrukkar A, Bhattacharjee A, Swain M, Mathrudev V, Nawale K, Balaji A, Peelay Z, Alone M, Pathak S, Mahajan A, Kumar S, Purandare N, Agarwal A, Puranik A, Pendse S, Reddy Yallala M, Sahu H, Kapu V, Dey S, Choudhary J, Krishna MR, Shetty A, Karuvandan N, Ravind R, Rai R, Jobanputra K, Chaturvedi P, Pai PS, Chaukar D, Nair S, Thiagarajan S, Prabhash K. Patil VM, et al. Among authors: rai r. J Clin Oncol. 2023 May 1;41(13):2350-2361. doi: 10.1200/JCO.22.00980. Epub 2023 Jan 27. J Clin Oncol. 2023. PMID: 36706347 Clinical Trial.
Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial.
Patil V, Noronha V, Dhumal SB, Joshi A, Menon N, Bhattacharjee A, Kulkarni S, Ankathi SK, Mahajan A, Sable N, Nawale K, Bhelekar A, Mukadam S, Chandrasekharan A, Das S, Vallathol D, D'Souza H, Kumar A, Agrawal A, Khaddar S, Rathnasamy N, Shenoy R, Kashyap L, Rai RK, Abraham G, Saha S, Majumdar S, Karuvandan N, Simha V, Babu V, Elamarthi P, Rajpurohit A, Kumar KAP, Srikanth A, Ravind R, Banavali S, Prabhash K. Patil V, et al. Among authors: rai rk. Lancet Glob Health. 2020 Sep;8(9):e1213-e1222. doi: 10.1016/S2214-109X(20)30275-8. Lancet Glob Health. 2020. PMID: 32827483 Free article. Clinical Trial.
Low-Dose Immunotherapy in Head and Neck Cancer: A Randomized Study.
Patil VM, Noronha V, Menon N, Rai R, Bhattacharjee A, Singh A, Nawale K, Jogdhankar S, Tambe R, Dhumal S, Sawant R, Alone M, Karla D, Peelay Z, Pathak S, Balaji A, Kumar S, Purandare N, Agarwal A, Puranik A, Mahajan A, Janu A, Kumar Singh G, Mittal N, Yadav S, Banavali S, Prabhash K. Patil VM, et al. Among authors: rai r. J Clin Oncol. 2023 Jan 10;41(2):222-232. doi: 10.1200/JCO.22.01015. Epub 2022 Oct 20. J Clin Oncol. 2023. PMID: 36265101 Clinical Trial.
Phase 3 RCT comparing docetaxel-platinum with docetaxel-platinum-5FU as neoadjuvant chemotherapy in borderline resectable oral cancer.
Noronha V, Patil V, Chaturvedi P, Mathrudev V, Menon N, Bhattacharjee A, Singh A, Peelay Z, Chakraborty S, Jadhav M, Alone M, Bhagyavant P, Kolkur M, Srinivas S, Das S, Roy S, Mandal T, Dsouza H, Saha S, Rai R, Srikanth A, Shah D, Khan A, Muthuluri H, Kumar A, Agarwal A, Rajpurohit A, Goli VB, Sekar A, Mantri A, Kanteti APK, Majumdar S, Khaddar S, Shenoy R, Elamarthi P, Rathnasamy N, Kashyap L, Abraham G, Booma N, Simha V, Chaukar D, Pai P, Nair S, Laskar S, Nawale K, Naidu P, Salian S, Shelar P, Raulo R, Dhumal SB, Prabhash K. Noronha V, et al. Among authors: rai r. Eur J Cancer. 2024 Mar;200:113560. doi: 10.1016/j.ejca.2024.113560. Epub 2024 Jan 20. Eur J Cancer. 2024. PMID: 38306841 Clinical Trial.
Neo-adjuvant chemotherapy followed by either continuous hyper-fractionated accelerated radiation therapy week-end less or conventional chemo-radiotherapy in locally advanced NSCLC-A randomised prospective single institute study.
Kumar R, Kumar HS, Paramanandhan M, Purohit R, Sharma N, Jakhar SL, Sharma S, Maharia S, Rai RK. Kumar R, et al. Among authors: rai rk. J Cancer Res Ther. 2020 Jul-Sep;16(4):860-866. doi: 10.4103/jcrt.JCRT_377_16. J Cancer Res Ther. 2020. PMID: 32930131 Free article. Clinical Trial.
Curbing the major and growing threats from invasive alien species is urgent and achievable.
Roy HE, Pauchard A, Stoett PJ, Renard Truong T, Meyerson LA, Bacher S, Galil BS, Hulme PE, Ikeda T, Kavileveettil S, McGeoch MA, Nuñez MA, Ordonez A, Rahlao SJ, Schwindt E, Seebens H, Sheppard AW, Vandvik V, Aleksanyan A, Ansong M, August T, Blanchard R, Brugnoli E, Bukombe JK, Bwalya B, Byun C, Camacho-Cervantes M, Cassey P, Castillo ML, Courchamp F, Dehnen-Schmutz K, Zenni RD, Egawa C, Essl F, Fayvush G, Fernandez RD, Fernandez M, Foxcroft LC, Genovesi P, Groom QJ, González AI, Helm A, Herrera I, Hiremath AJ, Howard PL, Hui C, Ikegami M, Keskin E, Koyama A, Ksenofontov S, Lenzner B, Lipinskaya T, Lockwood JL, Mangwa DC, Martinou AF, McDermott SM, Morales CL, Müllerová J, Mungi NA, Munishi LK, Ojaveer H, Pagad SN, Pallewatta NPKTS, Peacock LR, Per E, Pergl J, Preda C, Pyšek P, Rai RK, Ricciardi A, Richardson DM, Riley S, Rono BJ, Ryan-Colton E, Saeedi H, Shrestha BB, Simberloff D, Tawake A, Tricarico E, Vanderhoeven S, Vicente J, Vilà M, Wanzala W, Werenkraut V, Weyl OLF, Wilson JRU, Xavier RO, Ziller SR. Roy HE, et al. Among authors: rai rk. Nat Ecol Evol. 2024 Jun 3. doi: 10.1038/s41559-024-02412-w. Online ahead of print. Nat Ecol Evol. 2024. PMID: 38831016 Review.
Effects of pain education on disability, pain, quality of life, and self-efficacy in chronic low back pain: A randomized controlled trial.
Sidiq M, Muzaffar T, Janakiraman B, Masoodi S, Vasanthi RK, Ramachandran A, Bansal N, Chahal A, Kashoo FZ, Rizvi MR, Sharma A, Rai RH, Verma R, Sharma M, Alam S, Vajrala KR, Sharma J, Muthukrishnan R. Sidiq M, et al. Among authors: rai rh. PLoS One. 2024 May 28;19(5):e0294302. doi: 10.1371/journal.pone.0294302. eCollection 2024. PLoS One. 2024. PMID: 38805446 Free PMC article. Clinical Trial.
1,600 results